Nctc Material Transfer Agreement

A material transfer contract (MTA) is a contract that governs the transfer of research material between two organizations when the recipient intends to use it for his or her own research purposes. The MTA defines the rights of the supplier and recipient with respect to materials and derivatives. Biological materials such as reagents, cell lines, plasmids and vectors are the most frequently transferred materials, but MTAs can also be used for other types of materials, such as chemical compounds and even certain types of software. Typically, UH MTAs is required for all incoming or outgoing materials to monitor materials arriving on campus and materials (and to whom) UH provides. Every two years, the Texas Commission on Environmental Quality (TCEQ) transferred funds generated by landfill royalties to the 24 government councils (COG) in that state of Texas. COGs use these funds to develop and maintain a number of programs, including an inventory of MSW`s closed landfills, regional coordination and planning activities, a regional solid materials/waste management plan, and the management of the passport promotion program, among others. All 24 COGs are legally required to submit a report to the legislature every two years detailing the impact and results of passport grants. The Texas Association of Regional Councils (TARC) records these reports and summarizes them into a funding report. The latest report, published in February 2017, highlights the 2016-2017 fiscal year. Read this report and reports from previous years here. Check out the North Central Texas Council of Government`s Solid Waste implementation program by watching the video below. What is a Hardware Transfer Agreement (MTA)? A material transfer contract (MTA) is a legal contract required for the transfer of biological material between TTUHSC and academic, non-profit or industrial institutions for research purposes.

MTAs are designed to protect your intellectual property (IP) when you provide or receive research materials, such as cell lines, cultures, bacteria, nucleotides, proteins, transgenic animals, drugs and chemicals – in and through research institutes or companies.